Mark Hahn

Mark Hahn

63 year
Health Technology
Communications
Technology Services

Profile

Mark W.
Hahn
is an Independent Director at ALSP Orchid Acquisition Corp.
I since 2021.
Mr. Hahn is a Director at Opterion Health AG.
Former roles include Independent Director at Soleno Therapeutics, Inc. from 2025 to 2026; Chief Financial Officer at Charles & Colvard Ltd. from 1984 to 1996; Chief Financial Officer, Secretary & Treasurer at Verona Pharma Ltd.; Chief Financial Officer at Equitel, Inc.; Principal at Ernst & Young LLP; Chief Financial Officer at Athenix Corp.
from 2008 to 2009; Chief Financial Officer & VP-Administration at Gigabeam Corp.
from 2007 to 2008; Chief Financial Officer at BuildLinks, Inc. from 2002 to 2007; Chief Financial Officer & Executive Vice President at Cempra Pharmaceuticals, Inc. and Cempra, Inc. from 2010 to 2017; Chief Financial Officer at Performaworks, Inc.; and Chief Financial Officer at Dova Pharmaceuticals, Inc. from 2018 to 2019.
Education includes an undergraduate degree from the University of Wisconsin-Milwaukee conferred in 1984.

Mark Hahn active positions

CompaniesPositionStart
ALSP ORCHID ACQUISITION CORPORATION I Director/Board Member 2021-10-31
Director/Board Member -

Former positions of Mark Hahn

CompaniesPositionEnd
SOLENO THERAPEUTICS, INC. Director/Board Member 2026-05-14
DOVA PHARMACEUTICALS, INC. Director of Finance/CFO 2019-11-11
Director of Finance/CFO 2017-11-29
Director of Finance/CFO 2017-10-31
Director of Finance/CFO 2008-12-31
See the detail of Mark Hahn's experience

Training of Mark Hahn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

49

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Consumer Durables

Communications

Commercial Services

Process Industries

Communications

Technology Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Consumer Services

Health Technology

Health Services

Finance

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!